Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Escitalopram 10mg tablets
0403030X0AAAAAA
|
Escitalopram | Escitalopram | Central Nervous System | 185,688 |
|
Escitalopram 20mg tablets
0403030X0AAABAB
|
Escitalopram | Escitalopram | Central Nervous System | 137,750 |
|
Escitalopram 5mg tablets
0403030X0AAACAC
|
Escitalopram | Escitalopram | Central Nervous System | 91,189 |
|
Escitalopram 20mg/ml oral drops sugar free
0403030X0AAAFAF
|
Escitalopram | Escitalopram | Central Nervous System | 1,905 |
|
Escitalopram 10mg orodispersible tablets sugar free
0403030X0AAAHAH
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 10mg/ml oral drops sugar free
0403030X0AAADAD
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 15mg orodispersible tablets sugar free
0403030X0AAAIAI
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 20mg orodispersible tablets sugar free
0403030X0AAAJAJ
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 5mg orodispersible tablets sugar free
0403030X0AAAGAG
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.